Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 December 2004, Vol. 104, No. 13, pp. 4142-4149.
Prepublished online as a Blood First Edition Paper on August 24, 2004; DOI 10.1182/blood-2004-03-1190.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-03-1190v1
104/13/4142    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wysocka, M.
Right arrow Articles by Rook, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wysocka, M.
Right arrow Articles by Rook, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted March 30, 2004
Accepted August 11, 2004

Enhancement of the host immune responses in cutaneous T Cell lymphoma by CpG oligodeoxynucleotides and IL-15

Maria Wysocka*, Bernice M Benoit, Sarah Newton, Livio Azzoni, Luis J Montaner, and Alain Rook

Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA
The Wistar Institute, Philadelphia, PA, USA

* Corresponding author; email: mwysocka{at}mail.med.upenn.edu.

Patients with advanced cutaneous T cell lymphoma (CTCL) exhibit profound defects in cell-mediated immunity. Host immune functions appear to play an integral role in mediating disease-controlling responses in CTCL, therefore we investigated the effects of synthetic oligodeoxynucleotides with CpG motifs (CpG ODN), which have been recognized as immune stimulatory by virtue of activation of DCs following binding to Toll like receptor (TLR) 9. Peripheral blood mononuclear cells (PBMC) from patients with advanced CTCL (erythroderma with circulating malignant T cells) and normal volunteers were cultured with either CpG-A or CpG-B ODN. Patients' PBMC exhibited marked induction of IFN-{alpha} release following culture with CpG-A. Similarly significant activation of NK cells and CD8 T cells occurred as assessed by up-modulation of CD69 expression and by natural killer lytic activity. Nevertheless, the PBMC of patients exhibited blunted responses to CpG-A compared to normal volunteers. In such cases, IL-15 was capable of producing levels of NK activation that were superior to CpG-A, while the combined effects of CpG-A plus IL-15 induced maximal activation of NK cells and further enhanced activation of CD8 T cells. These findings have important implications for the potential enhancement of anti-tumor immunity among patients with advanced CTCL.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ann OncolHome page
P. Adam, B. Schmausser, M. Gobeler-Kolve, H. K. Muller-Hermelink, and M. Eck
Gastric extranodal marginal zone B-cell lymphomas of MALT type exclusively express toll-like receptor 4 in contrast to other lymphomas infiltrating the stomach
Ann. Onc., March 1, 2008; 19(3): 566 - 569.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. B. Smeltz
Profound Enhancement of the IL-12/IL-18 Pathway of IFN-{gamma} Secretion in Human CD8+ Memory T Cell Subsets via IL-15
J. Immunol., April 15, 2007; 178(8): 4786 - 4792.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. A. Stoklasek, K. S. Schluns, and L. Lefrancois
Combined IL-15/IL-15R{alpha} Immunotherapy Maximizes IL-15 Activity In Vivo
J. Immunol., November 1, 2006; 177(9): 6072 - 6080.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
S. T. Rosen and C. Querfeld
Primary Cutaneous T-Cell Lymphomas
Hematology, January 1, 2006; 2006(1): 323 - 330.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. S. Goddard, K.-i. Yamanaka, T. S. Kupper, and D. A. Jones
Activation of Neutrophils in Cutaneous T-Cell Lymphoma
Clin. Cancer Res., December 1, 2005; 11(23): 8243 - 8249.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020